An 8-week bemnifosbuvir-ruzasvir regimen leads to a sustained virologic response in 90% of treated patients with hepatitis C ...

Chimpanzees infected with hepatitis C virus in experiments decades ago at last received treatment using drugs made for humans ...

The US has curative HCV treatment and rapid tests but lags peer nations in prevention for people who inject drugs. The US is ...

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Hepatitis C is inflammation of the liver in humans caused by the hepatitis C virus. The virus is primarily transmitted by blood-to-blood contact associated with transfusion and intravenous drug use.

Simple oral direct-acting antiviral treatment for hepatitis C virus (HCV) infection has transformed clinical management and paved the way for elimination.1 The first pan-genotypic fixed-dose ...

The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, cannot be infected, which makes the search for a vaccine against HCV extremely ...

Characteristics of Hepatitis C. /Graphic=Design reporter Yoon Sun-jeong Cluster infection cases of "Hepatitis C," which is ...

In 2002, Pamela Anderson received a terrifying diagnosis: hepatitis C. Now, she's speaking out about the once incurable disease. The 59-year-old actress accepted the Award of Courage at the amfAR Gala ...

Researchers and clinicians at WashU Medicine are helping reshape how hepatitis C virus (HCV) is treated during pregnancy, with a new study showing that a commonly used antiviral regimen can be used ...

Hepatitis C is a type of blood-borne virus that targets the liver, causing inflammation and liver damage if untreated. It spreads between people by blood-to-blood contact. In cases covered by the ...

Glycolipid metabolism and microRNAs (miRNAs) play important roles in hepatitis C virus (HCV)-induced type 2 diabetes mellitus (T2DM). Our study aimed to explore the mechanism of action of miR-378b in ...